Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients84armbrca1breastbreast cancercancerhumanFalseE-GEOD-188643476tumor-expression-data-from-neoadjuvant-trial-of-ci6TWEAK-treated time course in ACHN cells24cancercellfibroblastspleenhumanFalseE-GEOD-420462260tweak-treated-time-course-in-achn-cells0TWEAK-treated time course in ACHN cells grown as xenografts62cancercellfibroblastspleenhumanFalseE-GEOD-420482259tweak-treated-time-course-in-achn-cells-grown-as-x0TWEAK-treated time course in MDA-MB-436 cells50cancercellfibroblastspleenhumanFalseE-GEOD-420452261tweak-treated-time-course-in-mda-mb-436-cells0TWEAK-treated time course in U2OS cells.50cancercellfibroblastspleenhumanFalseE-GEOD-418282262tweak-treated-time-course-in-u2os-cells2UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) is an inducer of apoptotic processes in Capan-1 pancreatic carcinoma cells: GNE silencing6cancerpancreatic cancerhumanFalseE-GEOD-223363698udp-glcnac-2-epimerasemannac-kinase-gne-is-an-indu1Under conditions of hormonal adjuvant treatment the estrogen receptor apoprotein supports breast cancer cell cycling through the retinoic acid receptor α1 apoprotein12basalbreastbreast cancercancercellestrogenglucoseglutaminehormonehumanFalseE-GEOD-262983901under-conditions-of-hormonal-adjuvant-treatment-th0Using gene chip technology to screen invasion related molecular targets of esophageal cancer cell lines6cancercarcinomacellesophageal cancersquamoussquamous carcinomahumanFalseE-GEOD-540412142using-gene-chip-technology-to-screen-invasion-rela1Usp44 binds centrin to regulate centrosome positioning and suppress tumorigenesis194adenocarcinomacancercentriolecentrosomechromosomelunglung adenocarcinomalung cancerproteinspindlehumanFalseE-GEOD-407912302usp44-binds-centrin-to-regulate-centrosome-positio6Variability in functional p53 reactivation by Prima-1Met/APR-246 in Ewing sarcoma12cancercelldiseaseewing sarcomasarcomahumanFalseE-GEOD-499672226variability-in-functional-p53-reactivation-by-prim2